Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of January 2020, with a filing date of January 15, 2020. The document serves as a transaction notification reporting changes in the notional interest of Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. The transactions were executed on January 13, 2020, on the London Stock Exchange (XLON) and the New York Stock Exchange (XNYS).
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the company. It exclusively details specific share transactions.
| Instrument | Transaction Price | Total Volume | Exchange |
|---|---|---|---|
| Ordinary Shares (GBP) | £17.9020 | 3,719 shares | London Stock Exchange |
| American Depositary Shares (USD) | $46.6500 | 764 ADSs | New York Stock Exchange |
Material Changes
The filing reports no material changes to the company's operations or financial position. The reported changes are limited to the increase in notional shareholdings for specific executives resulting from the re-investment of dividends paid on January 9, 2020, under the Company's Deferred Annual Bonus Plan.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. The document is a regulatory disclosure of insider trading activity compliant with Rule 13a-16 or 15d-16.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were automatic re-investments of dividends, not open-market purchases or sales by executives.
- Participants: Transactions involved 11 senior executives, including CEO Emma Walmsley, President of Global Vaccines Richard Connor, and President of Global Pharmaceuticals Luc Miels.
- Share Class Distinction: Executives held positions in both Ordinary Shares (traded in GBP) and American Depositary Shares (traded in USD).
- Timing: Transactions occurred on January 13, 2020, following a dividend payment date of January 9, 2020.